Chartier Stephane, Arif-Tiwari Hina
Department of Medical Imaging, College of Medicine, The University of Arizona, Tucson, AZ 85724, USA.
Cancers (Basel). 2023 May 17;15(10):2799. doi: 10.3390/cancers15102799.
Between 1983 and 2002, the incidence of solid renal tumors increased from 7.1 to 10.8 cases per 100,000. This is in large part due to the increase in the volume of ultrasound and cross-sectional imaging, although a majority of solid renal tumors are still found incidentally. Ultrasound and computed tomography (CT) have been the mainstay of renal mass screening and diagnosis but recent advances in magnetic resonance (MR) technology have made this the optimal choice when diagnosing and staging renal tumors. Our purpose in writing this review is to survey the modern MR imaging approach to benign and malignant solid renal tumors, consolidate the various imaging findings into an easy-to-read reference, and provide an imaging-based, algorithmic approach to renal mass characterization for clinicians. MR is at the forefront of renal mass characterization, surpassing ultrasound and CT in its ability to describe multiple tissue parameters and predict tumor biology. Cutting-edge MR protocols and the integration of diagnostic algorithms can improve patient outcomes, allowing the imager to narrow the differential and better guide oncologic and surgical management.
1983年至2002年间,实性肾肿瘤的发病率从每10万人7.1例增至10.8例。这在很大程度上归因于超声检查及断层成像检查数量的增加,尽管大多数实性肾肿瘤仍为偶然发现。超声和计算机断层扫描(CT)一直是肾脏肿块筛查和诊断的主要手段,但磁共振(MR)技术的最新进展使其成为诊断和分期肾肿瘤的最佳选择。我们撰写本综述的目的是探讨现代MR成像对良性和恶性实性肾肿瘤的检查方法,将各种影像学表现整合为易于阅读的参考资料,并为临床医生提供基于成像的、系统化的肾肿块特征分析方法。MR在肾肿块特征分析方面处于前沿地位,在描述多种组织参数及预测肿瘤生物学特性方面优于超声和CT。前沿的MR检查方案及诊断算法的整合可改善患者预后,使影像科医生能够缩小鉴别诊断范围,更好地指导肿瘤学及外科治疗。